MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
Institut du Cancer de Montpellier - Val d'Aurelle
National Institutes of Health Clinical Center (CC)
University of Utah
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Ohio State University Comprehensive Cancer Center
Royal North Shore Hospital
City of Hope Medical Center
City of Hope Medical Center
Taipei Veterans General Hospital, Taiwan
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Washington University School of Medicine
Thomas Jefferson University
Jonsson Comprehensive Cancer Center
Incyte Corporation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Yonsei University
Dana-Farber Cancer Institute
Northwestern University
Centre Hospitalier Régional d'Orléans
Indiana University
Zhejiang Cancer Hospital
Baylor College of Medicine
The Affiliated Hospital of Qingdao University
Barbara Ann Karmanos Cancer Institute
SCG Cell Therapy Pte. Ltd.
M.D. Anderson Cancer Center
Shanghai Bovax Biotechnology Co., Ltd.
Xi'an Jiaotong University
Ohio State University Comprehensive Cancer Center
Assiut University
Shanghai Bovax Biotechnology Co., Ltd.
Shanghai Bovax Biotechnology Co., Ltd.
National Cancer Institute (NCI)
HRYZ Biotech Co.
HRYZ Biotech Co.
Shanghai Bovax Biotechnology Co., Ltd.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
Dana-Farber Cancer Institute
Beijing Health Guard Biotechnology, Inc